Suicide substrates irreversible

Suicide substrate (irreversible inhibitor minus 02) (5HT-R) [CNS stimulatory NT, inhibits insulin secretion]... 

Suicide substrates and quiescent affinity labels, unlike the other types of inhibitors discussed in this chapter, form covalent bonds with active site nucleophiles and thereby irreversibly inactivate their target enzymes. A suicide substrate,191 also described by Silverman in a comprehensive review1101 as a mechanism-based inactivator, is a molecule that resembles its target enzyme s true substrate but contains a latent (relatively unreactive) electrophile. When the target enzyme attempts to turn over the... 

Silverman has pointed out that several criteria must be met to demonstrate that a compound is a true suicide substrate 1101 (1) Loss of enzyme activity must be time-dependent, and it must be first-order in [inactivator] at low concentrations and zero-order at higher concentrations (saturation kinetics), (2) substrate must protect the enzyme from inactivation (by blocking the active site), (3) the enzyme must be irreversibly inactivated and be shown to have a 11 stoichiometry of suicide substrate active site (dialysis of enzyme previously treated with radiolabeled suicide substrate must not release radiolabel into the buffer), (4) the enzyme must unmask the suicide substrate s potent electrophile via a catalytic step,1121 and (5) the enzyme must not be covalently labeled with the activated form of the suicide substrate following its escape from the active site (the presence of bulky scavenging thiol nucleophiles in the buffer must not decrease the observed rate of inactivation). 

Figure 7. Two examples of irreversible inactivators that are not suicide substrates a) TPCK, a classic" affinity label of the serine protease chymotrypsin, b) ZFK-CH2-mesitoate, a quiescent" affinity label of the cysteine protease cathepsin B, and c) the kinetic scheme for both forms of affinity label-inactivation.

These inactivators typically have negligible reactivity toward cellular nucleophiles, in contrast to the classic affinity labels and the activated (escaped) form of suicide substrates (I ). However, all classes of irreversible inactivators - even in the ideal case of covalently labeling only their target enzymes - suffer from the possibility of eliciting an undesired immune response against the inactivator-derivatized protein following protein denaturation and degradation.1171... 

An interesting dinically useful prodrug is 5-fluorouracil, which is converted in vivo to 5-fluoro-2 -deoxyuridine 5 -monophosphate, a potent irreversible inactivator of thymidylate synthase It is sometimes charaderized as a dead end inactivator rather than a suicide substrate since no electrophile is unmasked during attempted catalytic turnover. Rathei since a fluorine atom replaces the proton found on the normal substrate enzyme-catalyzed deprotonation at the 5 -position of uracil cannot occur. The enzyme-inactivator covalent addud (analogous to the normal enzyme-substrate covalent intermediate) therefore cannot break down and has reached a dead end (R. R. Rando, Mechanism-Based Enzyme Inadivators , Pharm. Rev. 1984,36,111-142). 

Allenic amino acids belong to the classical suicide substrates for the irreversible mechanism-based inhibition of enzymes [5], Among the different types of allenic substrates used for enzyme inhibition [128, 129], the deactivation of vitamin B6 (pyr-idoxal phosphate)-dependent decarboxylases by a-allenic a-amino acids plays an important role (Scheme 18.45). In analogy with the corresponding activity of other /3,y-unsaturated amino acids [102,130], it is assumed that the allenic amino acid 139 reacts with the decarboxylase 138 to furnish the imine 140, which is transformed into a Michael acceptor of type 141 by decarboxylation or deprotonation. Subsequent attack of a suitable nucleophilic group of the active site then leads to inhibition of the decarboxylase by irreversible formation of the adduct 142 [131,132]. 

Irreversible inhibition with based-mechanism inhibitors (suicide-substrates)... 

Irreversible Inhibition with Mechanism-Based inhibitors (Suicide Substrates)... 

Fluorinated substrates that are transformed into activated entities capable of reacting in an irreversible manner with the enzyme (mechanism-based inhibitors or suicide substrates). In the case of a mechanism-based inhibitor, the enzyme does not add onto the substrate itself, but onto an intermediate... 

As illustrated in Scheme 6.1, once the covalent intermediate is formed, the complex can either follow a normal catalytic cycle or go through a suicide event leading to the irreversible labeling that is necessary for selection. The suicide inhibition efficiency depends on the ratio k /k. This ratio depends on the nature of the suicide substrate and of the enzyme. Therefore, a large excess of suicide substrate as compared to the displayed enzyme is recommended for selection experiments. 

The compound 5-fluorouridine targets thymidylate synthase. After a nucleoside kinase phosphorylates it, resembles the natural substrate for the enzyme, except that it contains a fluorine where dUMP has a hydrogen. The fluorine isn t removed from the ring by thymidylate synthase, and this causes the ring to remain covalently bound to the enzyme, which means that the enzyme is irreversibly inactivated. The 5-fluorouridine monophosphate is an example of a suicide substrate —a compound whose reaction with an enzyme causes the enzyme to no longer function. 

The irreversible inhibition of enzymes by suicide substrates occurs as a consequence of activation steps in which the target enzymes transform these substrates into inhibitors using their normal mechanism. 

A final group of covalent small-molecule inhibitors of proteases are mechanism-based inhibitors. These inhibitors are enzyme-activated irreversible inhibitors, and they involve a two-hif mechanism that completely inhibits the protease. Some isocoumarins and -lactam derivatives have been shown to be mechanistic inhibitors of serine proteases. A classic example is the inhibition of elastase by several cephalosporin derivatives developed at Merck (Fig. 8). The catalytic serine attacks and opens the -lactam ring of the cephalosporin, which through various isomerization steps, allows for a Michael addition to the active site histidine and the formation of a stable enzyme-inhibitor complex (34). These mechanism-based inhibitors require an initial acylation event to take place before the irreversible inhibitory event. In this way, these small molecules have an analogous mechanism of inhibition to the naturally occurring serpins and a-2-macroglobin, which also act as suicide substrates. 

---